Find a Pharmacy
Vertice Login
Menu
close
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Industry Insights

Healthesystems' clinicians, data analysts, compliance officers, and business leaders are at the forefront of the issues and events that affect the workers’ compensation and healthcare industries.
Drawing on their expertise and insights, Healthesystems produces and publishes a variety of educational resources that help workers' compensation professionals stay informed and gain a deeper understanding of:
New drugs and other pharmacological updates
Medical equipment and service developments
Population demographics
Regulatory and policy news
Business, industry, and cultural trends

RxInformer

Award-winning journal providing in-depth analysis on today’s most important topics

Out of Balance: Workforce Gender Disparities and What They Mean for Workers’ Comp

Adverse effects of the pandemic on women, the workforce, and workers' comp
Winter 2021/2022

A Brighter Tomorrow? Applying Pandemic Lessons Today

A message from the Chief Executive Officer
Summer 2021

Home Alone: The Mental Health Impact of Working from Home

Extensive isolation and unique stressors may leave remote workers stressed
Summer 2021

Workers' Comprehensive

Monthly e-newsletter covering news stories relevant to workers’ compensation

FDA Approves Generic GLP-1 Victoza Injections for Type 2 Diabetes

Victoza® (liraglutide) injections are a GLP-1 receptor agonist, a drug class experiencing shortages due to their high demand.
Jan 2025

From A-to-Z: 5 Population Considerations for Gen Z

Health trends to consider in this growing portion of the workforce.
Jan 2025

FDA Issues Draft Guidance for the Use of AI in the Creation of Drugs and Medical Devices

The guidelines provide recommendations on using AI to demonstrate drug safety and effectiveness, and recommendations for AI-enabled medical devices.
Jan 2025

Clinical Guidance

“Clinical Minute” videos and other helpful resources from our clinical experts

COVID-19 and Clinical Trials

COVID-19 drug trials are underway, but the pandemic is disrupting clinical testing.
Mar 2020

JAMA Compares Effectiveness of Treatment Pathways for Opioid Use Disorder

A study of 41,000 adults finds that only treatment with buprenorphine or methadone reduced risk of overdose.
Mar 2020

WCIRB Publishes Physical Medicine Report

An analysis of 1.5 million claims found early physical therapy lowers odds of opioid use by 14%.
Feb 2020
1 … 17 18 19 20 21 … 28

Whitepapers

lockmap-markermagnifiercrossmenucross-circle